Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2005
11/08/2005US6962709 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
11/08/2005US6962708 Chimeric flavivirus vaccines
11/03/2005WO2005103272A2 Pan cancer oncolytic vectors and methods of use thereof
11/03/2005WO2005103237A1 Method of constructing recombinant herpes simplex virus
11/03/2005WO2005103236A1 A method for proliferating hepatitis c virus by using normal cells
11/03/2005WO2005103235A1 Method of producing virus
11/03/2005WO2005101966A2 Lipid-extracted therapeutic vaccine and method of use
11/03/2005WO2005070454A3 A novel process of hepatitis a vaccine preparation
11/03/2005WO2005055957A3 Influenza immunogen and vaccine
11/03/2005US20050244942 Adeno-associated virus; lysis, elution, ultrafiltration; gene therapy; chromatography
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244433 Administering vaccine comprising human papillomavirus L1 protein and excludes E protein to induce immune response
11/03/2005US20050244432 Expression of an L1 protein or functional protein derivative from two different types of papillomaviruses, and mixing the two; used for the prevention or treatment of a disease related to papillomavirus infection, such as cervical cancer or genital warts
11/03/2005US20050244431 Recombinant herpesvirus and polyvalent vaccine
11/03/2005US20050244430 Orthopoxvirus vectors, genes and products thereof
11/03/2005US20050244429 Live replicating spumavirus vector
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244381 Adenovirus including a gene coding for a superoxide dismutase
11/03/2005US20050244376 Modified viral surface proteins for binding to extracellular matrix components
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005CA2561691A1 Method of constructing recombinant herpes simplex virus
11/02/2005EP1590451A2 Alphavirus particles and methods for preparation
11/02/2005EP1590450A2 Recombinant virus production for the manufacturing of vaccines
11/02/2005EP1268524B1 Binding peptides for carcinoembryonic antigen (cea)
11/02/2005EP1200563B1 Attenuated influenza virus useful as vaccine
11/02/2005EP1182254B1 Methods for separating, fractionating and analyzing gene of virus existing in water
11/02/2005EP0962525B1 Phage bonded to nuclear location signal
11/02/2005CN1692156A Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
11/02/2005CN1690194A Bacteriophage for treating golden yellow staphylococcal bacteria infection
11/02/2005CN1225553C Recombinant pseudo-rabies virus expressing swine parvovirus VP gene and vaccine and its preparation method
11/02/2005CN1225283C Foot-and-mouth disease virus antigen dilution technology
11/01/2005US6960704 Isolated nucleic acid; genetic engineering
11/01/2005US6960569 Hepatitis C virus non-structural NS3/4A fusion gene
11/01/2005US6960428 Storage and maintenance of platelets
11/01/2005US6960345 Oral vaccinia formulation
11/01/2005CA2303526C Hepatitis c virus cell culture system
10/2005
10/27/2005WO2005100554A1 Novel infectious bursa fabricii's disease virus and vaccine containing the virus
10/27/2005WO2005049845A3 Oncolytic herpes simplex virus encoding a heterologous nitroreductase
10/27/2005WO2005026378A3 Methods for gene function analysis
10/27/2005US20050239205 Gb virus b based replicons and replicon enhanced cells
10/27/2005US20050239188 Virus envelope vector for gene transfer
10/27/2005US20050239187 Methods to culture circovirus
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239056 Methods and kits for predicting an infectious disease state
10/27/2005US20050239052 Cloning of rhadinovirus genome and methods for its use
10/27/2005US20050238670 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections
10/27/2005US20050238662 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying
10/27/2005US20050238661 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
10/27/2005US20050238656 Recombinant vesiculoviruses and their uses
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1588713A1 Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles
10/26/2005EP1588166A2 Dual expression vector system for antibody expression in bacterial and mammalian cells
10/26/2005EP1268851B1 Method of concentrating and recovering a viral enzyme activity from biological samples
10/26/2005CN1688702A Use of recombinant measles viruses expressing epitopes of antigens of RNA viruses in the preparation of vaccine compositions
10/26/2005CN1688335A Continuous cell line for the production of vaccines
10/26/2005CN1687407A Recombined T4 bacteriophage of expressing cholecystokinin gene
10/20/2005WO2005098009A2 Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/20/2005WO2005097981A2 Novel herpes simplex viruses
10/20/2005WO2005097821A1 Optimized expression of hpv 52 l1 in yeast
10/20/2005WO2005056583A3 Plant virus
10/20/2005WO2005049844A3 Vectors, mutant viruses and methods for generating mutant viruses
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005US20050235378 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
10/20/2005US20050233315 Cloned genes encoding reverse transcriptase lacking RNase H activity
10/20/2005US20050233311 Family of picornaviruses
10/20/2005US20050232950 Viruses comprising mutant ion channel protein
10/20/2005US20050232907 Use of herpes vectors for tumor therapy
10/20/2005US20050232900 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination
10/20/2005CA2799469A1 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/20/2005CA2560487A1 Optimized expression of hpv 52 l1 in yeast
10/19/2005EP1586634A1 Method of producing infectious reovirus
10/19/2005EP1585964A2 Chromatographic methods for adenovirus purification
10/19/2005EP1585812A2 Multi-antigenic alphavirus replicon particles and methods
10/19/2005EP1585535A2 Pthrp-derived modulators of smooth muscle proliferation
10/19/2005EP1104482B1 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
10/19/2005EP1002054B1 Process for the production of virus in cell cultures
10/19/2005CN1223682C Diagnose test
10/19/2005CN1223377C Selection and production of inactivated vaccine Lu 8 line of hepatitis A
10/18/2005US6956117 Highly conserved non-translated regions are mutated to give rise to RNA sequence that provides greater efficiency of transduction/replication
10/18/2005CA2283280C Reovirus for the treatment of neoplasia
10/13/2005WO2005095442A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/13/2005WO2005038035A3 Methods for producing and using in vivo pseudotyped retroviruses
10/13/2005WO2005028658A9 Recombinant influenza vectors with a polii promoter and ribozymes
10/13/2005WO2003068954A8 Microorganism for genetic therapeutic treatment of proliferative diseases
10/13/2005US20050227224 Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
10/13/2005US20050226893 Lyophilization method to improve excipient crystallization
10/13/2005US20050226892 Methods and compositions comprising bacteriophage nanoparticles
10/13/2005US20050226851 Lysin-deficient bacteriophages having reduced immunogenicity
10/13/2005DE102004013335A1 Impfstoff gegen Influenza basierend auf Geflügelpestviren Influenza vaccine based on avian influenza
10/13/2005CA2561376A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/12/2005EP1583824A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
10/12/2005EP1583772A2 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
10/12/2005EP1583560A1 Composition for intracellular transport of biological particles or macromolecules
10/12/2005EP1294918B1 Replication deficient adenoviral tnf vector
10/12/2005CN1681919A Chicken astrovirus type 2
10/12/2005CN1681917A Animal protein free media for cultivation of cells
10/12/2005CN1680592A Diagnostic assay
10/12/2005CN1679932A Ordered molecular presentation of antigens, method of preparation and use
10/11/2005USRE38824 biologically pure, isolated human B lymphotropic virus, molecular clones, nucleic acids, distinctive antigenic proteins and a method for detecting antibodies to the new virus
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 267